David Madtes

Associate Professor
Pulmonary and Critical Care Medicine
Fred Hutchinson Cancer Rearch Center
United States of America

Professor Pulmonology
Biography

Dr. Madtes is a pulmonary and critical care specialist with over 28 years of experience in lung cancer early detection, lung cancer screening, minimally invasive diagnostic procedures for lung cancer diagnosis and treatment of pulmonary complications related to oncologic diseases. His education and training include a B.A. from Gettysburg College in 1974, an M.D. from the University of Pittsburgh in 1979, residency training in internal medicine at the University of Rochester in 1983 and fellowship training in pulmonary and critical care medicine at the University of Washington in 1986. Dr. Madtes has distinguished himself as a physician, researcher and teacher. He is a prolific researcher, publishing over 64 refereed articles and 4 book chapters since 1984. He is the director of the Lung Cancer Early Detection and Prevention and the Lung Cancer CT Screening Programs at the Seattle Cancer Care Alliance. He is a full member in the Clinical Research Division of the Fred Hutchinson Cancer Research Center and section head of Pulmonary and Critical Care Medicine at the Fred Hutchinson Cancer Research Center. He has been honored with Seattle Magazine’s Top Doctors Award (2013, 2014, 2015).

Research Intrest

The focus of research is on the cellular and molecular mechanisms responsible for normal alveolar development and repair and for the fibroproliferative response that results in pulmonary fibrosis. Two primary projects: are 1) the identification of growth factors that regulate the cellular proliferation and extracellular matrix remodeling in the injured alveolus and in the developing lung; and 2) the identification of matrix metalloproteinases and tissue inhibitors of metalloproteinases responsible for extracellular remodeling in lung fibrosis.

List of Publications
Madtes DK, Elston AL, Hackman RC, Dunn AR, Clark JG. Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice. Am J Respir Cell Mol Biol 20:924-934, 1999.
Madtes DK, Rubenfeld G, Klima LD, Milberg JA, Steinberg KP, Martin TM, Raghu G, Hudson LD, Clark JC. Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am J Resp Crit Care Med 158:424-430, 1998.
Madtes DK, Busby HK, Strandjord TP, Clark JG. Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin induced lung injury in rats. Am J Respir Cell Mol Biol 11:540-551, 1994.
Strandjord TP, Clark JG, Hodson WA, Schmidt RA, Madtes DK. Expression of transforming growth factor-alpha in mid-gestation human fetal lung. Am J Respir Cell Mol Biol 8:266-272, 1993.
Madtes DK, Raines EW, Sakariassen KS, Assoian RK, Sporn MB, Bell GI, and Ross R. Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell 53:285-293, 1988.